Vilaprisan for the treatment of symptomatic endometriosis: results from a terminated phase 2b randomized controlled trial

• Autors principals: Hugh S. Taylor, M.D (Autor), Liying Dong, M.D., Ph.D (Autor), Johanna Haikonen, M.D (Autor), Peter Oppelt, M.D (Autor), Karl Tamussino, M.D (Autor), Rene Wenzl, M.D., Ph.D (Autor), Thomas Faustmann, M.D (Autor), Esther Groettrup-Wolfers, M.D., Ph.D (Autor), Xiaowei Ren, Ph.D (Autor), Christian Seitz, M.D., Ph.D (Autor)
• Format: Llibre
• Publicat: Elsevier, 2024-06-01T00:00:00Z.
• Matèries: article
• Accés en línia: Connect to this object online.

Objective: To evaluate the efficacy and safety of 2 doses of vilaprisan vs. placebo in participants with symptomatic endometriosis. Design: Multicenter, randomized, double-blind, placebo-controlled, parallel-group phase 2b trial (NCT03573336). The initially planned sample size was 315 patients. Recr...